Novel pyrazolo[1,5-a]pyridines as PI3K inhibitors: variation of the central linker group

被引：14

作者：

Kendall, Jackie D. ^{[1
,2
]}

Marshall, Andrew J. ^{[1
]}

Giddens, Anna C. ^{[1
]}

Tsang, Kit Yee ^{[1
]}

Boyd, Maruta ^{[1
]}

Frederick, Raphael ^{[1
]}

Lill, Claire L. ^{[3
]}

Lee, Woo-Jeong ^{[3
]}

Kolekar, Sharada ^{[3
]}

Chao, Mindy ^{[3
]}

Malik, Alisha ^{[3
]}

Yu, Shuqiao ^{[3
]}

Chaussade, Claire ^{[2
,3
]}

Buchanan, Christina M. ^{[2
,3
]}

Rewcastle, Gordon W. ^{[1
,2
]}

Baguley, Bruce C. ^{[1
,2
]}

Flanagan, Jack U. ^{[1
,2
]}

Denny, William A. ^{[1
,2
]}

Shepherd, Peter R. ^{[2
,3
]}

机构：

[1] Univ Auckland, Sch Med & Hlth Sci, Auckland Canc Soc Res Ctr, Auckland 1142, New Zealand

[2] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand

[3] Univ Auckland, Sch Med & Hlth Sci, Dept Mol Med & Pathol, Auckland 1142, New Zealand

来源：

MEDCHEMCOMM | 2014年 / 5卷 / 01期

关键词：

KINASE-INHIBITORS; PATHWAY INHIBITORS; P110-ALPHA; THIOAMIDES; DISCOVERY; CANCER; DESIGN;

D O I：

10.1039/c3md00221g

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

As part of our investigation into the pyrazolo[1,5-a] pyridines as novel PI3K inhibitors, we report a range of analogues where the central linker portion of the molecule was varied while retaining the pyrazolo[1,5-a] pyridine and arylsulfonyl or arylcarbonyl groups. Isostere generating software BROOD was used to assist with producing ideas. The isoform selectivity of the compounds varied from pan-PI3K for compound 41 to p110 alpha-selective for compound 58 or p110 delta-selective for compound 57. The latter two compounds varied only in their sulphur oxidation state.

引用

页码：41 / 46

页数：6

共 50 条

[21] Pyrazolo[1,5-a]pyrimidines as novel COX-2 selective inhibitors
Barlocco, D
DRUG DISCOVERY TODAY, 2001, 6 (11) : 595 - 595
[22] Novel 1,5-naphthyridine PI3Kδ inhibitors, an evaluation of WO2011075628
Norman, Peter
EXPERT OPINION ON THERAPEUTIC PATENTS, 2011, 21 (11) : 1805 - 1810
[23] Novel inhibitors of the PI3K family
Carnero, Amancio
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (09) : 1265 - 1277
[24] Discovery and SAR of novel pyrazolo[1,5-a]pyrimidines as inhibitors of CDK9
Phillipson, Louisa J.
Segal, David H.
Nero, Tracy L.
Parker, Michael W.
Wan, Soo San
de Silva, Melanie
Guthridge, Mark A.
Wei, Andrew H.
Burns, Christopher J.
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (19) : 6280 - 6296
[25] HETEROCYCLIC SYNTHESIS WITH NITRILES - SYNTHESES OF SOME NOVEL PYRAZOLO[1,5-A]PYRIMIDINE AND PYRROLO[2',3'-3,4]PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES
ABDELRAZEK, FM
JOURNAL FUR PRAKTISCHE CHEMIE, 1989, 331 (03): : 475 - 478
[26] ACID-CATALYZED REACTIONS OF 3-(ALPHA-HYDROXYBENZYL)PYRAZOLO[1,5-A]PYRIDINES
MIKI, Y
TOMII, O
NAKAO, H
KUBO, M
HACHIKEN, H
TAKEMURA, S
IKEDA, M
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1988, 25 (01) : 327 - 331
[27] AN EFFICIENT TWO-STEP SYNTHESIS OF NOVEL SUBSTITUTED PYRAZOLO[1,5-a]-[1,3,5]-TRIAZINES AND PYRAZOLO[1,5-a]-[1,3,5] TRIAZINONES
Bokri, Khouloud
Efrit, Mohamed Lotfi
Ben Akacha, Azaiez
HETEROCYCLIC LETTERS, 2015, 5 (04): : 679 - 685
[28] Synthesis and Bioactivity of Pyrazolo[1,5-a]pyrimidine Derivatives as Novel c-Met Inhibitors
Ni, Chunyan
Zhang, Yuting
Zhao, Yu
Zhu, Li
CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2012, 32 (12) : 2294 - 2299
[29] Investigation of pyrazolo[1,5-a]quinoxalin-4-ones as novel monoamine oxidase inhibitors
Panova, Valeria A.
Filimonov, Sergey I.
Chirkova, Zhanna V.
Kabanova, Mariya V.
Shetnev, Anton A.
Korsakov, Mikhail K.
Petzer, Anel
Petzer, Jacobus P.
Suponitsky, Kyrill Yu
BIOORGANIC CHEMISTRY, 2021, 108
[30] A new synthetic route to fluorinated pyrazolo[3,4-b]pyridines and their use in the preparation of novel pyrido[2',3':3,4]pyrazolo[1,5-a]pyrimidines
Chandra, Sheker Reddy, A.
Narsaiah, B.
Venkataratnam, R. V.
Journal of Fluorine Chemistry, 86 (02):

← 1 2 3 4 5 →